How to Read and Interpret a FibroScan Report

A FibroScan report comes down to two readings: how stiff your liver is, which hints at scarring, and how much fat it holds. Higher numbers generally mean more of each, but neither one is a verdict on its own. The same stiffness number can mean different things depending on what is affecting your liver, and a liver can read stiffer than it really is on the day of the scan.¹ The report works best as a well-informed estimate that your doctor reads together with blood tests and your history.

The Two Numbers on Your Report

The probe sends a gentle vibration through your skin into the liver and times how fast the wave travels. The wave moves faster through a stiffer liver, so a faster wave gives a higher score.² The result appears as liver stiffness (often shortened to LSM) in kilopascals, or kPa. Scarring makes liver tissue stiffer, which is why kPa is used to estimate it.

The second number, CAP (controlled attenuation parameter), is measured during the same scan.³ It tracks how much the signal fades as it passes through the liver, and fat increases that fading.⁴ CAP is reported in decibels per meter (dB/m), and a higher CAP means more fat.⁵

On a real report, the stiffness value is usually labelled E or LSM with kPa beside it. CAP appears separately, with dB/m units. Many reports also list a median and an IQR, and some print a suggested F or S stage next to the numbers.

Stiffness and fat are separate questions. A liver can be fatty without being scarred. Scarring is the bigger long-term concern because it can progress to cirrhosis, while fat is often the earlier and more reversible problem.

The probe is pressed against the skin between your lower right ribs, and each measurement takes only a few seconds. The test is painless. Most people feel only a light tap or flick, and how the scan felt tells you nothing about how high or low your numbers are.

What Your Stiffness Score Says About Scarring

F0 to F1: no scarring or mild scarring.⁶
F2: moderate scarring.⁷
F3: severe scarring.⁸
F4: advanced scarring, also called cirrhosis, the highest score.⁹

The kPa ranges that match each stage are estimates, not exact lines.¹⁰ Reference tables first ask which liver disease you have, then where your stiffness falls.¹¹ That is because the best cutoffs for advanced scarring and cirrhosis differ between causes of liver disease.¹²

To use your report’s table, find your diagnosis in the first column, find the row containing your kPa value, and read across to the matching F score. If you have more than one condition, ask your doctor which row they used.

Many reports apply one default set of cutoffs to everyone, so the stage printed beside your number may come from a table built for a different liver disease than yours. If that printed stage and your doctor’s stated stage differ, the likely reason is that your doctor used cutoffs matched to your own condition, not that one of them made a mistake.

Some examples show how much the cutoffs move. In fatty liver disease, below about 8.8 kPa makes advanced scarring unlikely and above about 10.9 kPa makes it likely.¹³ In people with both hepatitis B and fatty liver, about 8.0 kPa catches most significant scarring, and above about 17.8 kPa strongly points to cirrhosis.¹⁴ Numbers in between form a grey zone where doctors often add another test.¹⁵

A grey-zone number sits where people with and without advanced scarring overlap. The usual response is a further test, such as a blood score like FIB-4, an MRI-based scan, or sometimes a repeat FibroScan, rather than a firm conclusion either way. Your doctor also weighs context such as diabetes, weight, and liver blood tests, because the same grey-zone number is more worrying in someone with several risk factors.

A low stiffness score is good at ruling out advanced scarring, so a result below the lower cutoff for your condition is genuinely reassuring. A high score can be inflated by temporary things like inflammation or a recent meal, so it works best as a reason to look further. F4 on a scan is not a confirmed cirrhosis diagnosis. That usually rests on several pieces of evidence together, such as blood tests, imaging, and your history, and sometimes a biopsy. A single high number calls for confirmation, not panic.

What Your CAP Score Says About Liver Fat

These cutoffs were set to catch most people with fat, so some people above them have less than the number suggests.²⁰ Some clinics use slightly different CAP cutoffs, so check the range printed on your report.

CAP is a rougher guide than the stiffness score. It reflects the average amount of fat across the small section of liver the probe samples, so it gives a broad grade and not a precise fat percentage. Two scans of the same liver can give CAP values that differ by a noticeable amount, so small changes between visits may not mean real change. A result near a grade boundary, such as close to 252 dB/m, could reasonably fall in either grade.

Fat in the liver is common and often has no symptoms. It is closely tied to weight, diabetes, and alcohol, and it can fall with weight loss and less alcohol. An S0 result means little or no fat by this test, though it says nothing about scarring, which the stiffness score covers. An S1 to S3 result suggests fatty liver, and the grade mainly tells your doctor how much fat there is, not how much damage has been done. Your doctor cares most about whether fat comes with scarring, so the grade becomes more meaningful next to your stiffness score: fat with low stiffness is a very different picture from fat with high stiffness.

Things That Can Make Your Liver Read Stiffer Than It Is

Stiffness can rise within 30 minutes of a meal, in one study from about 6.1 to 6.8 kPa on average.²¹ The rise was clear in people with liver disease, not in healthy volunteers.²² That average rise was under one kPa, which is small, but it can matter when your result sits close to a cutoff between stages. Eating within 3 hours of the exam can falsely raise readings.²³ Alcohol inflames the liver briefly and can raise stiffness, so clinics ask you to avoid it for at least 24 hours.²⁴

Active inflammation from hepatitis, alcohol, or autoimmune disease can make stiffness overstate scarring.²⁵ Your blood test lists ALT, a liver enzyme that rises when the liver is inflamed. In hepatitis C, about 3–5% of people with normal liver enzyme levels read as cirrhosis, versus about 19–28% of those with ALT above 120.²⁶ In hepatitis B, higher liver enzyme levels push stiffness up most for people with little scarring.²⁷ Inflammation can settle with treatment or time, while scarring tends to stay, so a person with hepatitis can show a worrying score during a flare and a lower one once the liver calms down.

Heart failure and blood congestion in the liver can also raise stiffness.²⁸ Blocked bile ducts and amyloidosis are other known causes.²⁹

If a reading seems off, tell your doctor if you ate or drank shortly before, and mention any recent heavy drinking or heart conditions. Ask whether your enzyme level was high at scan time. A repeat scan makes sense after inflammation settles and under proper fasting, so the results can be compared fairly.

Checking Whether Your Reading Is Reliable

The machine takes about ten valid readings and reports their median, the middle value. One unusually high or low reading therefore does not drag the final score far.³⁰ The IQR/Med figure shows how spread out those readings were, which is something the median alone cannot tell you. Look for it near the median on your report and compare it to 0.3.

A value of 0.1 or less is very reliable. Up to 0.3 is reliable, as is a value above 0.3 when the median is under 7.1 kPa. Above 0.3 with a median of 7.1 kPa or more is poor reliability.³¹

The 7.1 exception exists because a small scatter looks large when divided by a small number. If your reliability is poor, ask about a repeat.

The probe matters too. The M probe suits most people, and the XL probe is for larger bodies.³² A larger waist and a thicker distance from skin to liver make M probe readings less reliable.³³ Newer machines suggest the right probe automatically.³⁴

How Your Doctor Uses the Result With Other Tests

FibroScan is good at ruling out advanced scarring in fatty liver.³⁵ The FIB-4 blood score from routine labs is better at confirming it.³⁶ Using both catches more cases.³⁷

FIB-4 is calculated from your age, two liver enzyme results, and your platelet count, all from routine blood tests. Those results are usually already in your chart, so no extra test is needed.

MR elastography is more accurate than FibroScan for scarring,³⁸ and this holds in hepatitis B too.³⁹ It is done inside an MRI scanner with a soft pad over the liver area that sends gentle vibrations, and you hold your breath briefly for each image. It measures stiffness across a larger part of the liver, which is part of why it is more accurate. MRI costs more and takes longer, and it is booked as an MRI appointment, so FibroScan is often first and MRI is kept for unclear or high-stakes cases.

In people with advanced liver disease, 15 kPa or less plus normal platelets makes high liver blood pressure unlikely.⁴⁰ A score of 25 kPa or more signals high pressure and may prompt a scope.⁴¹

In practice, a low result usually means routine follow-up, a grey-zone result means another test, and a high result means referral to a specialist.

Preparing for a Scan and Comparing Results Over Time

Avoid solid food for three hours before the scan.⁴² Water is usually fine, but confirm with your clinic, since instructions can differ between places. Follow the clinic’s instructions on alcohol too, since recent drinking can raise the number. Keep taking your usual medicines unless the clinic says otherwise, and mention what you take.

Wear a loose shirt.⁴³ A loose or two-piece outfit gives the technician easy access to the skin of your right lower chest, where the probe goes. You lie on your back with your right arm raised above your head and feel a gentle flick.⁴⁴ The raised arm widens the spaces between the ribs so the probe can reach the liver. To make follow-up scans comparable, fast the same way each time, bring your old reports, and ask whether the same probe will be used.

Scores can improve. In hepatitis B treatment, average stiffness fell from 14.5 to 8.3 kPa over five years.⁴⁵ Scores also improved after hepatitis C cure in transplant patients.⁴⁶

1
PubMed Central. Update of liver fibrosis and steatosis with transient elastography (Fibroscan) ↩︎
2
Australian Family Physician. FibroScan and transient elastography ↩︎
3
PubMed. Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan: validation in chronic hepatitis C ↩︎
4
PubMed. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan ↩︎
5
PubMed. Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography ↩︎
6
Rumah Sakit Abdi Waluyo. Understanding your FibroScan Results ↩︎
7
Rumah Sakit Abdi Waluyo. Understanding your FibroScan Results ↩︎
8
Rumah Sakit Abdi Waluyo. Understanding your FibroScan Results ↩︎
9
Associates in Gastroenterology. FibroScan ↩︎
10
Memorial Sloan Kettering Cancer Center. How to Read and Interpret a FibroScan Report ↩︎
11
Memorial Sloan Kettering Cancer Center. How to Read and Interpret a FibroScan Report ↩︎
12
PubMed Central. Update of liver fibrosis and steatosis with transient elastography (Fibroscan) ↩︎
13
PubMed. The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study ↩︎
14
PubMed Central. Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease ↩︎
15
PubMed. Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD ↩︎
16
PubMed. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography ↩︎
17
PubMed. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography ↩︎
18
PubMed. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography ↩︎
19
PubMed. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography ↩︎
20
PubMed. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography ↩︎
21
PubMed Central. Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter ↩︎
22
PubMed Central. Effect of Meal Ingestion on Liver Stiffness and Controlled Attenuation Parameter ↩︎
23
Mednet. What factors can lead to falsely elevated fibrosis readings on FibroScan (e.g., consuming sugar before the scan)? ↩︎
24
Endocrine & Diabetes Plus Clinic of Houston. Preparing for Your FibroScan ↩︎
25
Mednet. What factors can lead to falsely elevated fibrosis readings on FibroScan (e.g., consuming sugar before the scan)? ↩︎
26
PubMed Central. Levels of Alanine Aminotransferase Confound Use of Transient Elastography to Diagnose Fibrosis in Patients with Chronic HCV Infection ↩︎
27
PubMed. Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B ↩︎
28
Mednet. What factors can lead to falsely elevated fibrosis readings on FibroScan (e.g., consuming sugar before the scan)? ↩︎
29
PubMed Central. Confounding factors of non-invasive tests for nonalcoholic fatty liver disease ↩︎
30
PubMed Central. Diagnostic Accuracy of FibroScan and Factors Affecting Measurements ↩︎
31
PubMed Central. Diagnostic Accuracy of FibroScan and Factors Affecting Measurements ↩︎
32
City Imaging. Why FibroScan with XL Probe is Recommended for Obese Patients ↩︎
33
PubMed. Impact of anthropometric features on the applicability and accuracy of FibroScan(®) (M and XL) in overweight/obese patients ↩︎
34
Echosens. VCTE Probes – XL, M, S & Pediatric Models ↩︎
35
PubMed. Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD ↩︎
36
PubMed. Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLD ↩︎
37
PubMed. The diagnostic utility of fibrosis-4 or nonalcoholic fatty liver disease fibrosis score combined with liver stiffness measurement by fibroscan in assessment of advanced liver fibrosis: a biopsy-proven nonalcoholic fatty liver disease study ↩︎
38
PubMed Central. Magnetic Resonance vs Transient Elastography Analysis of Patients With Non-alcoholic Fatty Liver Disease: a Systematic Review and Pooled Analysis of Individual Participants ↩︎
39
PubMed Central. Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis ↩︎
40
PubMed Central. Baveno VII – Renewing consensus in portal hypertension ↩︎
41
PubMed Central. Baveno VII – Renewing consensus in portal hypertension ↩︎
42
Portland Gastroenterology Center. FibroScan Prep – Portland Gastroenterology Center ↩︎
43
Portland Gastroenterology Center. FibroScan Prep – Portland Gastroenterology Center ↩︎
44
Endocrine & Diabetes Plus Clinic of Houston. Preparing for Your FibroScan ↩︎
45
PubMed. Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis ↩︎
46
PubMed. Longitudinal assessment of hepatic fibrosis in responders to direct-acting antivirals for recurrent hepatitis C after liver transplantation using noninvasive methods ↩︎